Gene · 6281
Papers4,430
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,430
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma. | Int J Mol Sci | 2022 | 36232334 | PubTator, text mining | PubMed |
| Effects of Mindfulness for Performance Programme on Actual Performance in Ecological Sport Context: Two Studies in Basketball and Table Tennis. | Int J Environ Res Public Health | 2022 | 36232246 | PubTator, text mining | PubMed |
| Bioinformatics and Functional Analysis of a New Nuclear Localization Sequence of the Influenza A Virus Nucleoprotein. | Cells | 2022 | 36230922 | PubTator, text mining | PubMed |
| Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach. | Cancers (Basel) | 2022 | 36230614 | PubTator, text mining | PubMed |
| POP1 inhibits MSU-induced inflammasome activation and ameliorates gout. | Front Immunol | 2022 | 36225929 | PubTator, text mining | PubMed |
| A qualitative interview study of GPs' experiences of prescribing opioid medication for chronic pain. | BJGP Open | 2022 | 36216370 | PubTator, text mining | PubMed |
| Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications. | Acta Pharm Sin B | 2022 | 36213540 | PubTator, text mining | PubMed |
| The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases. | Oxid Med Cell Longev | 2022 | 36211819 | PubTator, text mining | PubMed |
| Genetic engineering of baculovirus-insect cell system to improve protein production. | Front Bioeng Biotechnol | 2022 | 36204465 | PubTator, text mining | PubMed |
| Machine learning identifies exosome features related to hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | 36200042 | PubTator, text mining | PubMed |
| The resealing factor S100A11 interacts with annexins and extended synaptotagmin-1 in the course of plasma membrane wound repair. | Front Cell Dev Biol | 2022 | 36200035 | PubTator, text mining | PubMed |
| The dynamics of the general practitioner-nephrologist collaboration for the management of patients with chronic kidney disease before and after dialysis initiation: a mixed-methods study. | Ther Adv Chronic Dis | 2022 | 36199764 | PubTator, text mining | PubMed |
| Subclones of bone marrow CD34+ cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy. | Cancer | 2022 | 36197314 | PubTator, text mining | PubMed |
| Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors. | Oxid Med Cell Longev | 2022 | 36193060 | PubTator, text mining | PubMed |
| A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma. | Front Oncol | 2022 | 36185203 | PubTator, text mining | PubMed |
| Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease. | Diabetes Care | 2022 | 36174116 | PubTator, text mining | PubMed |
| New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors. | Front Pharmacol | 2022 | 36172198 | PubTator, text mining | PubMed |
| Multi-context genetic modeling of transcriptional regulation resolves novel disease loci. | Nat Commun | 2022 | 36171194 | PubTator, text mining | PubMed |
| Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming. | Cell Oncol (Dordr) | 2022 | 36169805 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6281/papers?page=37